Holdings (Monthly)
Guide ↗
First Trust Nasdaq Pharmaceuticals ETF
· First Trust Exchange-Traded Fund VI| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Johnson & Johnson | JNJ | Jun 2023 | 8,893 | $2.2M | 7.45% | EC |
| 2 | Bristol-Myers Squibb Company | BMY | Jun 2023 | 35,422 | $2.1M | 7.36% | EC |
| 3 | Merck & Co., Inc | MRK | Jun 2023 | 17,843 | $2.1M | 7.36% | EC |
| 4 | AbbVie Inc. | ABBV | Jun 2023 | 9,520 | $2.1M | 7.10% | EC |
| 5 | Eli Lilly & Co. | LLY | Jun 2023 | 2,100 | $1.9M | 6.62% | EC |
| 6 | Pfizer Inc. | PFE | Jun 2023 | 39,951 | $1.1M | 3.85% | EC |
| 7 | Regeneron Pharmaceuticals, Inc. | REGN | Jun 2023 | 1,413 | $1.1M | 3.74% | EC |
| 8 | Biogen Inc | BIIB | Jun 2023 | 5,759 | $1.1M | 3.62% | EC |
| 9 | Gilead Sciences Inc. | GILD | Jun 2023 | 7,416 | $1.0M | 3.54% | EC |
| 10 | Cardinal Health, Inc. | CAH | Jun 2023 | 4,819 | $1.0M | 3.49% | EC |
| 11 | Amgen Inc. | AMGN | Jun 2023 | 2,846 | $1.0M | 3.43% | EC |
| 12 | Viatris Inc | VTRS | Jun 2023 | 73,989 | $1000K | 3.43% | EC |
| 13 | Zoetis Inc. | ZTS | Jun 2023 | 8,426 | $996K | 3.41% | EC |
| 14 | Vertex Pharmaceuticals Incorporated | VRTX | Jun 2023 | 2,223 | $993K | 3.40% | EC |
| 15 | United Therapeutics Corporation | UTHR | Jun 2023 | 1,630 | $967K | 3.31% | EC |
| 16 | Incyte Corporation. | INCY | Jun 2023 | 6,843 | $644K | 2.21% | EC |
| 17 | Jazz Pharmaceuticals PLC | JAZZ | Jun 2023 | 3,347 | $633K | 2.17% | EC |
| 18 | Illumina Inc | ILMN | Mar 2026 | 3,657 | $451K | 1.55% | EC |
| 19 | Exelixis, Inc. | EXEL | Jun 2023 | 10,279 | $441K | 1.51% | EC |
| 20 | Medpace Holdings Inc. | MEDP | Jun 2023 | 865 | $415K | 1.42% | EC |
| 21 | PTC Therapeutics, Inc. | PTCT | Jun 2023 | 5,449 | $371K | 1.27% | EC |
| 22 | Charles River Laboratories International, Inc. | CRL | Jun 2023 | 2,127 | $367K | 1.26% | EC |
| 23 | Biomarin Pharmaceutical Inc. | BMRN | Jun 2023 | 6,318 | $357K | 1.22% | EC |
| 24 | Neurocrine Biosciences Inc | NBIX | Jun 2023 | 2,630 | $346K | 1.19% | EC |
| 25 | Halozyme Therapeutics Inc | HALO | Jun 2023 | 5,005 | $323K | 1.11% | EC |
| 26 | Alkermes PLC | ALKS | Jun 2023 | 8,380 | $296K | 1.02% | EC |
| 27 | Elanco Animal Health Inc | ELAN | Jun 2023 | 10,925 | $261K | 0.90% | EC |
| 28 | Spyre Therapeutics Inc | SYRE | Mar 2026 | 3,533 | $178K | 0.61% | EC |
| 29 | Protagonist Therapeutics Inc | PTGX | Mar 2026 | 1,650 | $174K | 0.60% | EC |
| 30 | TG Therapeutics Inc | TGTX | Mar 2026 | 5,049 | $168K | 0.57% | EC |
| 31 | Arrowhead Pharmaceuticals Inc | ARWR | Mar 2026 | 2,611 | $164K | 0.56% | EC |
| 32 | Catalyst Pharmaceuticals Inc. | CPRX | Mar 2026 | 6,583 | $163K | 0.56% | EC |
| 33 | Amneal Pharmaceuticals Inc | AMRX | Mar 2026 | 12,984 | $161K | 0.55% | EC |
| 34 | ARCUS BIOSCIENCES INC | RCUS | Mar 2026 | 7,459 | $161K | 0.55% | EC |
| 35 | Twist Bioscience Corporation | TWST | Mar 2026 | 3,238 | $154K | 0.53% | EC |
| 36 | Ligand Pharmaceuticals Incorporated | LGND | Mar 2026 | 766 | $153K | 0.52% | EC |
| 37 | Mirum Pharmaceuticals Inc. | MIRM | Mar 2026 | 1,646 | $152K | 0.52% | EC |
| 38 | Travere Therapeutics Inc | TVTX | Mar 2026 | 5,100 | $152K | 0.52% | EC |
| 39 | Alnylam Pharmaceuticals Inc. | ALNY | Jun 2023 | 456 | $151K | 0.52% | EC |
| 40 | Guardant Health Inc | GH | Mar 2026 | 1,618 | $149K | 0.51% | EC |
| 41 | Roivant Sciences Ltd | ROIV | Jun 2023 | 5,250 | $145K | 0.50% | EC |
| 42 | Moderna Inc | MRNA | Jun 2023 | 2,836 | $144K | 0.49% | EC |
| 43 | Supernus Pharmaceuticals, Inc | SUPN | Mar 2026 | 2,776 | $143K | 0.49% | EC |
| 44 | Krystal Biotech Inc | KRYS | Mar 2026 | 551 | $142K | 0.49% | EC |
| 45 | Tarsus Pharmaceuticals Inc | TARS | Mar 2026 | 2,012 | $141K | 0.48% | EC |
| 46 | Ionis Pharmaceuticals, Inc. | IONS | Jun 2023 | 1,872 | $141K | 0.48% | EC |
| 47 | 10X Genomics Inc | TXG | Mar 2026 | 6,591 | $140K | 0.48% | EC |
| 48 | Kymera Therapeutics Inc | KYMR | Mar 2026 | 1,663 | $139K | 0.47% | EC |
| 49 | Acadia Pharmaceuticals Inc | ACAD | Jun 2023 | 6,186 | $138K | 0.47% | EC |
| 50 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | Mar 2026 | 5,633 | $133K | 0.45% | EC |
| 51 | Dreyfus Government Cash Management Funds | MISXX | Mar 2026 | 32,295 | $32K | 0.11% | STIV |